We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CP icon
401
Canadian Pacific Kansas City
CP
$78.3B
$40K 0.01%
850
GDX icon
402
PUT
VanEck Gold Miners ETF
GDX
$23.5B
$38.6K 0.01%
+1,250
New +$27.5K
JNPR
403
DELISTED
Juniper Networks
JNPR
$36.1K 0.01%
1,355
-948
-41% -$25.3K
RGLD icon
404
Royal Gold
RGLD
$17.2B
$35.7K 0.01%
348
-798
-70% -$71.9K
WMT icon
405
Walmart Inc
WMT
$884B
$35K 0.01%
951
-4,545
-83% -$157K
VTR icon
406
Ventas
VTR
$44.7B
$34.9K 0.01%
511
-43
-8% -$2.74K
VALE icon
407
PUT
Vale
VALE
$63.8B
$34.5K 0.01%
1,000
COP icon
408
ConocoPhillips
COP
$145B
$32.7K 0.01%
537
-2,767
-84% -$172K
ALB icon
409
Albemarle
ALB
$13.9B
$32K 0.01%
+455
New +$33.6K
GTX icon
410
Garrett Motion
GTX
$5.78B
$31.7K 0.01%
2,063
CLVS
411
DELISTED
Clovis Oncology, Inc.
CLVS
$31.2K 0.01%
2,100
IBN icon
412
ICICI Bank
IBN
$109B
$30.2K 0.01%
2,396
+1,130
+89% +$13.1K
GAU
413
Galiano Gold
GAU
$468M
$28.5K 0.01%
45,000
SNA icon
414
Snap-on
SNA
$21.2B
$27K ﹤0.01%
163
-1
-0.6% -$163
RACE icon
415
PUT
Ferrari
RACE
$69.9B
$25.9K ﹤0.01%
767
-28
-4% -$4.03K
OVV icon
416
Ovintiv
OVV
$17B
$25.7K ﹤0.01%
1,000
LOGI icon
417
PUT
Logitech
LOGI
$14.6B
$24.2K ﹤0.01%
739
AZO icon
418
AutoZone
AZO
$49.1B
$24.2K ﹤0.01%
+22
New +$23.2K
SCHW
419
Charles Schwab
SCHW
$181B
$23.1K ﹤0.01%
575
-920
-62% -$40.1K
HOG icon
420
Harley-Davidson
HOG
$2.59B
$22.9K ﹤0.01%
640
-771
-55% -$28K
KLAC icon
421
KLA
KLAC
$236B
$22.1K ﹤0.01%
1,870
+1,640
+713% +$19K
FSM icon
422
Fortuna Silver Mines
FSM
$2.66B
$21.9K ﹤0.01%
7,700
BRZU icon
423
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$104M
$21.1K ﹤0.01%
18
-27
-60% -$26.5K
LYV icon
424
Live Nation Entertainment
LYV
$42.7B
$20.9K ﹤0.01%
+315
New +$20.2K
KDP icon
425
Keurig Dr Pepper
KDP
$43B
$20.7K ﹤0.01%
717
-116
-14% -$3.31K

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.